Arcutis Biotherapeutics Inc (ARQT)
SG&A Expenses
$82.14M
Quarterly · Period ending: · USD
ARQT SG&A Expenses
Latest reported$82.14Mperiod ending
Latest reported$82.14Mperiod ending
ARQT Quarterly SG&A Expenses ($287.50K → $82.14M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ARQT sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 82,138,000 | |
| 74,076,000 | |
| 78,977,000 | |
| 62,404,000 | |
| 69,170,000 | |
| 64,002,000 | |
| 57,607,000 | |
| 58,817,000 | |
| 58,173,000 | |
| 54,794,000 | |
| 48,674,000 | |
| 47,595,000 | |
| 45,958,000 | |
| 42,918,000 | |
| 37,023,000 | |
| 35,473,000 | |
| 27,622,000 | |
| 22,006,000 | |
| 18,728,000 | |
| 16,474,000 | |
| 11,315,000 | |
| 14,454,000 | |
| 6,690,000 | |
| 5,560,000 | |
| 5,618,000 | |
| 3,469,000 | |
| 2,237,000 | |
| 2,300,000 | |
| 1,324,000 | |
| 749,000 | |
| 606,000 | |
| 614,000 | |
| 287,500 | |
| 287,500 |